Literature DB >> 18330099

Management and treatment of chronic hepatitis B virus: Belgian Association for the Study of the Liver (BASL) 2007 guidelines.

I Colle1, M Adler, R Brenard, J Henrion, P Langlet, P Michielsen, H Orlent, H Reynaert, D Sprengers, P Stärkel, P Van Damme, C Verslype, J Delwaide.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 18330099

Source DB:  PubMed          Journal:  Acta Gastroenterol Belg        ISSN： 1784-3227            Impact factor:   1.316


× No keyword cloud information.
  2 in total

1.  Stopping nucleos(t)ide analogue treatment in Caucasian hepatitis B patients after HBeAg seroconversion is associated with high relapse rates and fatal outcomes.

Authors:  S Van Hees; S Bourgeois; H Van Vlierberghe; T Sersté; S Francque; P Michielsen; D Sprengers; H Reynaert; J Henrion; S Negrin Dastis; J Delwaide; L Lasser; J Decaestecker; H Orlent; F Janssens; G Robaeys; I Colle; P Stärkel; C Moreno; F Nevens; T Vanwolleghem
Journal:  Aliment Pharmacol Ther       Date:  2018-03-02       Impact factor: 8.171

2.  Efficacy of consensus interferon in treatment of HbeAg-positive chronic hepatitis B: a multicentre, randomized controlled trial.

Authors:  YongLi Zheng; LianSan Zhao; TaiXiang Wu; ShuHua Guo; YaGang Chen; TaoYou Zhou
Journal:  Virol J       Date:  2009-07-09       Impact factor: 4.099
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.